Showing results (51-60 of 83) with videos related to
Sort By:
Pageof 9
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 28, 2018
Reduced clearance of venlafaxine in a combined treatment with quetiapineMichael Paulzen, Georgios Schoretsanitis, Christoph Hiemke, et al.Plos One|June 6, 2012
Brain circuitries involved in semantic interference by demands of emotional and non-emotional distractorsNatalia Chechko, Thilo Kellermann, Michael Zvyagintsev, et al.Archives of Women'S Mental Health|August 18, 2018
Antidepressants in breast milk; comparative analysis of excretion ratiosGeorgios Schoretsanitis, Marc Augustin, Helena Saßmannshausen, et al.Schizophrenia Research|June 12, 2019
Effect of fluvoxamine augmentation and smoking on clozapine serum concentrationsMarc Augustin, Georgios Schoretsanitis, Philippe Pfeifer, et al.The Journal of Clinical Psychiatry|September 8, 2018
Differences in Duloxetine Dosing Strategies in Smoking and Nonsmoking Patients: Therapeutic Drug Monitoring Uncovers the Impact on Drug MetabolismMarc Augustin, Georgios Schoretsanitis, Christoph Hiemke, et al.Journal of Affective Disorders|February 12, 2013
Brain circuitries involved in emotional interference task in major depression disorderNatalia Chechko, Marc Augustin, Michael Zvyagintsev, et al.International Journal of Bipolar Disorders|December 16, 2014
Antidepressant dosage taken by patients with bipolar disorder: factors associated with irregularityRita Bauer, Tasha Glenn, Martin Alda, et al.International Journal of Psychiatry in Clinical Practice|July 5, 2014
Adjunctive lithium treatment in the prevention of suicidal behavior in patients with depression and comorbid personality disordersFelicitas Rombold, Eric Lauterbach, Werner Felber, et al.Schizophrenia Research|October 3, 2017
Pregnancy exposure to quetiapine - Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood and obstetrical outcomesMichael Paulzen, Tamme W Goecke, Maxim Kuzin, et al.Journal of Affective Disorders|February 15, 2020
Pregnancy exposure to venlafaxine-Therapeutic drug monitoring in maternal blood, amniotic fluid and umbilical cord blood and obstetrical outcomesMichael Paulzen, Georgios Schoretsanitis, Gerhard Gründer, et al.Pageof 9